This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Harvard President Claudine Gay is under fire not just for her answers before Congress, but allegations of plagiarism. Here's what's going on. The post Understanding the Claudine Gay Plagiarism Scandal appeared first on Plagiarism Today.
Photo: Author The CBC—which, by the way, has just announced it will be cutting 10% of its workforce owing to reductions in the funding it receives from Parliament, cuts that unfortunately will probably curb its investigative programming—has “revealed” that works by a number of prominent Canadian authors such as Margaret Atwood, Alice Munro, Robertson Davies, … Continue reading "CBC Investigation Documents the Challenge for Writers: Works by Prominent Canadian Authors are Included in AI Tr
Allgenesis Biotherapeutics Inc. v. Cloudbreak Therapeutics, LLC addresses whether an IPR petitioner can assert Article III standing on appeal based on potential infringement liability and potential preclusive effects on its patents. Background Cloudbreak owns U.S. Patent No. 10,149,820 (the “’820 patent”), which is directed to compositions and methods for treating pterygium.
Artificial intelligence has the potential to make our lives more efficient, entertaining, and productive. On the flip side, it also presents several threats. This ranges from complex existential worries to concerns about AI-related copyright infringement, which is already widespread. Tthese copyright concerns will be discussed next month at a meeting of WIPO’s Advisory Committee on Enforcement, where several stakeholders will present their thoughts.
Software is complex, which makes threats to the software supply chain more real every day. 64% of organizations have been impacted by a software supply chain attack and 60% of data breaches are due to unpatched software vulnerabilities. In the U.S. alone, cyber losses totaled $10.3 billion in 2022. All of these stats beg the question, “Do you know what’s in your software?
A viral TikTok warns students, if your work is submitted to Turnitin, you need to uninstall Grammarly. Is this true and, if so, why? The post Should Students Stop Using Grammarly? appeared first on Plagiarism Today.
After years of battles over Bills C-11 and C-18, few Canadians will have the appetite for yet another troubling Internet bill. But given a bill that envisions government-backed censorship, mandates age verification to use search engines or social media sites, and creates a framework for court-ordered website blocking, there is a need to pay attention.
In Medtronic, Inc., Medtronic Vascular, Inc. v. Teleflex Innovations S.A.R.L. , the case addresses whether the final written decisions in a consolidated inter partes appeal (“IPR”) correctly found that U.S. Patent 7,736,355 (“the ’355 patent”) does not qualify as prior art to related U.S. Patents 8,048,032, RE45,380, RE45,776, RE45,760, and RE47,379 (collectively, “the challenged patents”) under pre-AIA’s first-to-invent provisions.
In Medtronic, Inc., Medtronic Vascular, Inc. v. Teleflex Innovations S.A.R.L. , the case addresses whether the final written decisions in a consolidated inter partes appeal (“IPR”) correctly found that U.S. Patent 7,736,355 (“the ’355 patent”) does not qualify as prior art to related U.S. Patents 8,048,032, RE45,380, RE45,776, RE45,760, and RE47,379 (collectively, “the challenged patents”) under pre-AIA’s first-to-invent provisions.
Over the past year, artificial intelligence enjoyed its mainstream breakthrough. The instant success of ChatGPT and follow-up releases of other large language model-based tools kickstarted what many believe is a new revolution. By now it is clear that AI offers endless possibilities. At the same time, however, it has ignited many new worries. Copyright holders, in particular, are concerned that their work is being used as training models but without permission. ‘Piracy-Trained’ AI Mo
With the launch of Grok, xAI's new AI system, questions arose about where its data came from and if it was copying OpenAI's homework. The post When AI Plagiarizes AI appeared first on Plagiarism Today.
The legal and ethical concerns surrounding generative artificial intelligence (AI) systems being trained on copyrighted works are currently under scrutiny, with the U.S. Copyright Office conducting an Artificial Intelligence Study […] The post Generative AI, Copyrighted Works, and the Quest for Ethical Training Practices appeared first on Copyright Alliance.
The Federal Circuit vacated and remanded two Patent Trial and Appeal Board (“PTAB”) decisions because the PTAB erred in its obviousness analysis and found that Axonics failed to show a motivation to combine as to Medtronic’s ‘314 and ‘756 patents. Background Medtronic sued Axonics for patent infringement. Medtronic’s invention concerns a medical device that stimulates sacral nerves.
Women and diverse employees have the technical skill and knowledge, yet their contributions are not patented at the same rate as those of their male counterparts.This toolkit can help organizations move the needle on achieving gender parity in innovation.
On December 11, the Review Board of the U.S. Copyright Office (USCO) released a letter affirming the USCO’s refusal to register a work created with the use of artificial intelligence (AI) software. The decision to affirm the refusal marks the fourth time a registrant has been documented as being denied the ability to obtain a copyright registration over the output of an AI system following requests for reconsideration.
Authors consolidate and refile AI case against Meta, pirate TV services sued in New York and new details about Italy's Piracy Shield. The post 3 Count: Consolidating Meta appeared first on Plagiarism Today.
Erik introduces you to the new USPTO search engine and shares his thoughts about the updated platform in this podcast. The post All About the New USPTO Trademark Search System appeared first on Erik M Pelton & Associates, PLLC. Erik introduces you to the new USPTO search engine and shares his thoughts about the updated platform in this podcast.
In Medtronic, Inc., Medtronic Vascular, Inc., v. Teleflex Innovations S.A.R.L. , the case addresses the weight the Patent Trial and Appeal Board (PTAB) should give to the intended purpose of a primary reference when evaluating a Person of Ordinary Skill in the Art’s (POSITA) motivation to combine that primary reference with secondary references. Background Teleflex Innovation S.A.R.L.
by guest blogger Christine Haight Farley Because it is grading season, when I read the Second Circuit’s per curiam decision in Vans, Inc. v. MSCHF Prod. Studio, Inc. , 2023 U.S. App. LEXIS 32063 (2d Cir. 2023), I already had my red grading pen out. The low grade the court earned is a consequence of it losing many points by misstating the law, misapplying the law, and especially skipping over the part where it was supposed to share its analysis and instead just stated its conclusion.
Marvel settles final copyright termination dispute, Piracy Shield goes online in Italy and Adam McKay faces Don't Look Up lawsuit. The post 3 Count: Avengers Assemble appeared first on Plagiarism Today.
With all the talk about AI, one might think the problem of old-school media piracy has abated, but this week, the House Judiciary Committee held a hearing entitled Digital Copyright Piracy: Protecting American Consumers, Workers, and Creators. Although much of the conversation was familiar territory (i.e., the economic value of the creative industries and the […] The post Is Site Blocking Finally Within Sight?
In United Therapeutics Corp. v Liquidia Tech Inc. , the Federal Circuit reviewed the district court’s decision on invalidity and infringement of two pharmaceutical patents and the impact of the Final Written Decision (FWD) in a parallel inter-partes review (IPR) upon the district court’s decision. Background Liquidia filed a New Drug Application for Yutrepia TM , its non-generic dry powder inhalation formulation of the drug treprostinil, under § 505(b)(2) of the Food, Drug, and Cosmetic Act.
Over the past several years we’ve covered dozens of copyright troll cases against tens of thousands of alleged copyright infringers. Our coverage mostly focuses on piracy-related cases, but there are other variants too. Outfits that target blogs and other websites for using photos without permission, for example. The definition of the term ‘copyright troll’ is fluid.
US ISP hit with massive copyright lawsuit, trial over Disney-used face capture software continues and Spotify will not leave Uruguay. The post 3 Count: Spotify’s Return appeared first on Plagiarism Today.
This Kat is always on the hunt for new copyright rulings. This time he has found a recent ruling issued by the Paris Court of Appeal , concerning a copyright assignment agreement, a subject that is the source of many disputes in France. This time, the dispute notably concerns both the originality of photographs and their use for a period exceeding that stipulated in the copyright assignment contract.
In Malvern Panalytical Inc. v. TA Instruments-Waters LLC , the Federal Circuit addressed the proper construction of the claim term “pipette guiding mechanism.” Specifically, the Federal Circuit found the plain and ordinary meaning of “pipette guiding mechanism” sufficient and addressed how various claim construction doctrines affected its analysis, including the use of a non-related patent cited in an IDS as intrinsic evidence.
A few years ago, Epic Games filed copyright infringement lawsuits against several Fortnite players who allegedly used cheats to gain an unfair advantage. The legal campaign sent a clear signal to the gaming public that people who try to scam the system can get caught. Today, these lawsuits have disappeared from the radar and it’s unknown whether the intended goal was achieved.
The U.S. Copyright Office on Monday again denied an artist's attempt to register his van Gogh-inspired artwork generated by artificial intelligence, saying there's not enough human involvement for the artist to claim copyright.
The recent Board of Appeal decision in T 1356/21 covered a number of interesting legal points in the field of pharmaceutical patents. The case related to the novelty and inventive step of a second medical use claim. The only distinguishing feature of the claim in view of the prior art was the specified concentration of the active substance (insulin) in the pharmaceutical formulation.
In ABS Global, Inc., Genus plc v. Cytonome/ST, LLC , the case addresses a claim construction issue regarding whether a claim term is plural-allowing. Background ABS Global Inc. and Genus plc (collectively, ABS) petitioned for an inter partes review of claims 1, 2, 6, 8, and 9 of U.S. Patent No. 10,583,439 (the “’439 patent”) owned by Cytonome/ST, LLC.
After years of relative calm, punctuated by intermittent action against larger operations, law enforcement actions against pirate IPTV services in Europe are on the rise. The UK’s Eastern Region Special Operations Unit (ERSOU), a regional force with responsibility for disrupting organized crime and counter terrorism policing, has revealed details of raids executed on Tuesday targeting a pirate IPTV operation.
In the previous posts on this series of the Toyota Practical Problem Solving (PPS) I went into detail on how to understand the problem by clarifying the problem and breaking it down to get the prioritized problem. In this post I will look at target setting and root-cause analysis. Setting the target and doing the. Read more The post Toyota Practical Problem Solving (PPS)—Targets and Root Causes first appeared on AllAboutLean.com.
On December 8, 2023, the FDA approved the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older—Vertex’s CASGEVY and Bluebird’s LYFGENIA. SCD is a group of inherited blood disorders affecting approximately 100,000 people in the U.S. and inducing a median life expectancy of 45 years.
Over the last year, the Federal Circuit has suspended one of its own judges, Delaware's chief federal judge has told the U.S. Department of Justice to investigate attorneys practicing in his court, and the Federal Circuit vacated a huge infringement verdict. Here's what you need to know about these cases and other major decisions in 2023.
When U.S. broadcaster DISH Network files another new lawsuit in the U.S., targeting various players in the IPTV ecosystem, the company maintains a long tradition of legal action that aims high and goes in hard. While DISH headlines all of these lawsuits with various appearances from Nagra and subsidiary Sling TV, behind the scenes DISH receives support from fellow members of IBCAP, the International Broadcaster Coalition Against Piracy.
What this is : In this article we focus on filing UCC-3 amendments to terminate existing UCC-1 financing statements. What this means : Whether you are a UCC secured party or potential lender there are many things to consider not only when determining the effectiveness of a UCC filing, but also when preparing and filing UCC financing statement amendments better known as UCC-3 forms.
Celltrion Submits Denosumab BLA to FDA: On November 30, 2023, it was reported that Celltrion had completed submission of its application to the FDA for CT-P41, its denosumab biosimilar of Amgen’s PROLIA and XGEVA.
Twitter suspended the plaintiff’s Twitter account @Zay_Cipher. He wanted access to his content, so he requested an account download. However, he says the download links provided by Twitter were “defective,” so he sued Twitter pro se. Conversion. “Plaintiff’s simple act of tweeting does not create any ‘thing’ on which to base his conversion claim.” Good Faith and Fair Dealing.
The launch of the BeStreamWise online anti-piracy campaign early October was preceded by action in the ‘real’ world. After being offered free lifetime subscriptions to a new streaming service from a pop-up stand in London’s Paddington Station, commuters were encouraged to sign up to ‘MalStreams’ using their real personal details.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content